Zhongyi Xu

16PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsCancer diagnosisPredictive and prognostic markersMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 17, 2025
Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study.

Zhongyi Xu, Yijie Xuan, Zhe Zhu

|Sep 06, 2025
Treatment of Acquired Dermal Macular Hyperpigmentation With Oral Isotretinoin: A Multi-Institutional Retrospective Study of 121 Cases.

Zhongyi Xu, Yuecen Ding, Chengfeng Zhang

|Mar 08, 2024
Efficacy and safety of the combination of oral tranexamic acid and intense pulsed light versus oral tranexamic acid alone in the treatment of refractory Riehl's melanosis: A prospective, comparative study.

Zhongyi Xu, Chen Wang, Xiaoxue Xing

|Jul 04, 2023
Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment.

Yuecen Ding, Zhongyi Xu, Leihong Flora Xiang

|Feb 26, 2022
Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo.

Xiuyi Wu, Shanglin Jin, Yiwen Yang

|Jan 28, 2022
Implications of Oxidative Stress in the Pathogenesis and Treatment of Hyperpigmentation Disorders.

Xiaoxue Xing, Yanjun Dan, Zhongyi Xu

Pageof 3

Frequent Collaborators

12 joint publications

Chengfeng Zhang

7 joint publications

Leihong Xiang

5 joint publications

Xiaoxue Xing

3 joint publications

Jie Shen